Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 10, 2015

Khoja et al v. Orexigen Therapeutics, Inc. et al

Track this case

Case Number:

3:15-cv-00540

Court:

California Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Janis L. Sammartino

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. April 23, 2021

    Pharma Co.'s $4.8M Investor Deal OK'd, But Fees Undecided

    A California federal judge on Thursday preliminarily granted a $4.8 million proposed settlement to resolve allegations that Orexigen Therapeutics had a duty to warn investors after learning a drug wasn't as beneficial as earlier data indicated, but questioned class counsel's requested amount in attorney fees.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login